Abstract
Background
Hyponatremia (serum sodium lower than 135 mmol/L) is the most frequent electrolyte alteration diagnosed in medical practice. It has deleterious clinical effects, being an independent predictor of mortality. Malnutrition encompasses pathological states caused by both nutrients excess and deficiency, being frequently documented in chronic kidney disease patients. In addition, chronic hyponatremia promotes adiposity loss and sarcopenia, while malnutrition can induce hyponatremia. This pathological interaction is mediated by four main mechanisms: altered electrolyte body composition (low sodium, low potassium, low phosphorus, or high-water body content), systemic inflammation (cytokines increase), hormonal mechanisms (renin–angiotensin–aldosterone system activation, vasopressin release), and anorexia (primary or secondary).
Conclusion
Malnutrition can induce hyponatremia through hydro-electrolytic, hormonal, inflammatory, or nutritional behavior changes; while hyponatremia per se can induce malnutrition, so there is a pathophysiological feedback between both conditions.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hyponatremia, defined as natremia < 135 mmol/L, is the most frequent electrolyte alteration diagnosed in medical practice. Its importance relies not only on its deleterious effects, (neurologic symptoms, risk to falls, and osteoporosis development) but also on being an independent predictor of mortality. Probably, hyponatremia is simultaneously a severity marker of the underlying condition, and a direct contributor to poor prognosis [1].
The term malnutrition encompasses pathological states caused by both excess and deficiency of nutrients, which consists of a disorder of body composition characterized by an excess of extracellular water, frequently associated with a decrease in muscle and fat tissue, hypoproteinemia, and potassium deficiency. Moreover, this condition interferes with the host normal response to disease and treatment. Since malnutrition is frequently documented in chronic kidney disease (CKD) and end-stage renal disease (ESRD), the understanding of its pathophysiological mechanisms has led the International Society of Renal Nutrition and Metabolism (ISRNM) to coin a particular term to this condition known as protein-energy wasting syndrome (PEW) [2]. PEW is characterized by simultaneous loss of systemic body protein and energy storages, including muscle and fat wasting and visceral protein pool contraction. This phenomenon has been attributed to proinflammatory cytokines activation combined with superimposed hypercatabolic states, and appetite decline. The latter might be caused by uremia, or inflammation secondary to CKD inducing systemic conditions, such as diabetes mellitus or autoimmune diseases [3, 4]. The evidence tends to suggest that PEW develops more in patients from CKD stage 3b (estimated glomerular filtration rate < 45 mL/min) onwards, as defined by the Kidney Disease Improving Global Outcomes (KDIGO) staging of CKD [3].
In addition, it has been documented that PEW prevalence showed is 60–82% in AKI patients, 11–54% in 3–5 CKD patients, 28–52% in hemodialysis patients, and 40–45% in transplanted patients [4, 5]. Finally, malnutrition can be associated with sarcopenia and cachexia. Sarcopenia consists of significant muscle mass and strength loss of multifactorial etiology, which is associated with PEW in CKD patients, limiting patient’s autonomy and quality of life [6, 7]. Regarding cachexia, it refers to a very severe form of PEW, often associated with profound physiological, metabolic, psychological, and immunological disorders [4].
Hyponatremia and malnutrition are frequently found associated, and they have been even reported as associated with higher mortality, particularly in chronic hemodialysis patients [7,8,9]. In the present article, the fundamentals of the association between these two conditions are analyzed.
Hyponatremia in malnutrition: its pathophysiology
-
1.
Altered electrolyte body composition
Five main hyponatremia inducing mechanisms have been, all of which can be documented in malnourished patients (Fig. 1):
Firstly, the mechanisms which consist of an inadequate salt and water excretion, which can be subdivided in three main categories: (a) depletion in excess of salt (e.g., chronic diarrhea with water replacement in malabsoption syndrome), (b) salt and water body retention in excess of water (with or without edema), which may present with hypervolemia (e.g., renal failure, etc.), or effective hypovolemia (cardiac failure, etc.) in inflammatory states associated with chronic disease, and (c) inadequate water retention, as it happens for instance in paraneoplastic antidiuresis syndromes [1, 7,8,9].
Secondly, the mechanisms which consist of an inadequate salt and water income, which can be subdivided in two main categories: (a) low sodium diet, particularly in those malnourished patients suffering from anorexia and (b) excessive water income due to an increased thirst induced by high angiotensin II or inflammatory cytokines serum levels [9,10,11,12,13,14].
Thirdly, the other factor which can modify the sodium/water ratio of the body is the body potassium content since its intracellular depletion leads to low serum sodium levels by inducing sodium shift to the intracellular compartment, as well as inappropriate vasopressin release [8,9,10]. Precisely, hyponatremia secondary to low potassium body content can be documented in severe malnourished patients. Moreover, sarcopenia is a condition usually documented in this population, and since muscle mass is the main potassium body store, sarcopenia represents reduced body potassium content. Therefore, it has been hypothesized that sarcopenia per se, as a cause of low potassium body content, could cause hyponatremia [10, 18].
Edelman equation, a simplified version of Boling equation, summarized all these concepts in the following formula that describes how body sodium, potassium, and water determine serum sodium concentration [1]:
$$\mathrm{Serum}\;\mathrm{sodium}\;\mathrm{concentration}\:=\:\frac{\mathrm{body}\;\mathrm{sodium}+\mathrm{body}\;\mathrm{potassium}}{\mathrm{total}\;\mathrm{body}\;\mathrm{water}}$$Fourthly, Zeballos et al. have postulated the reduced body phosphorus content usually found in malnourished peritoneal dialysis (PD) patients as an alternative cause of hyponatremia in this population. They hypothesized that in some PD patients during catabolic state, ribonucleic acid can break down, passing organic phosphates to inorganic phosphates. These anions would then leave the cells together with potassium in order to maintain electroneutrality, generating an osmotic effect that would dilute the intravascular compartment, favoring the appearance of hyponatremia [6, 19, 20].
In the fifth place, reset osmostat (RO), a condition that has a low-normal plasma osmolality threshold which consequently induces vasopressin release at a lower plasma osmolarity, with normal water load excretion, and intact urine diluting ability, while maintaining normal sodium balance. RO has been documented in severely frail individuals [7,8,9,10,11,12].
Sixth, there is the combination of some of the abovementioned mechanisms, which is usually documented in this population, as is the typical case of a patient suffering from chronic diarrhea (high sodium loss) and hyporexia (low sodium income).
Seventh, it has already been documented a positive association between decreased lean body mass and low serum sodium levels, as well as that serum sodium tends to be low in the malnourished individuals [7, 8, 13, 14]. In this sense, Barsoney et al. have hypothesized based on animal studies that chronic hyponatremia can increase oxidative stress, promoting senescence manifestations, such as loss of adiposity, bone mass, and sarcopenia.
Finally, malnutrition-associated chronic conditions (advanced heart failure, cirrhosis, AIDS, etc.) or malnutrition itself, through its inflammatory status, could also induce hyponatremia [11, 15,16,17].
Since systemic inflammation, renin–angiotensin–aldosterone system (RAAS) activation, and anorexia are the main scenarios where the above-described hyponatremia inducing mechanisms are unfolded in malnourished individuals, they are described in detail as follows.
-
2.
Systemic inflammation
Inflammation is a possible pathogenetic pathway for the development of PEW and hyponatremia. On the one hand, chronic inflammation sends inflammatory signals to the hypothalamus which mediate energy wasting in chronic diseases. In addition, inflammatory activation of the hypothalamic receptors that control thirst has been suggested as another cause of hyponatremia by inducing excessive water ingestion [6, 8, 13, 21]. On the other hand, hyponatremia commonly appears in inflammatory states. This phenomenon could be explained since an interaction between interleukin-6 and vasopressin-induced antidiuresis has been proposed, based on animal experimental data [6, 8, 13, 22].
Moreover, inflammation was associated with hyponatremia, independent from the presence or the absence of malnutrition. It has been observed an inverse relation between white blood cell count and serum sodium levels in hemodialysis patients, and hyponatremia was frequently associated with chronic infection, and other chronic inflammatory diseases. It has been suggested that either hyponatremia per se or by mucosal barrier breakdown through cellular edema could stimulate inflammation. Additionally, non-osmotic storage of sodium may induce the synthesis of interleukin-17 by CD4 + T-helper cells, which may contribute to chronic systemic inflammation [7, 8].
-
3.
Hormonal mechanisms
RASS can be activated by real or effective hypovolemia. Regarding the former, this can be documented in malnourished patients who suffer from volume contraction due to a chronic low sodium diet (salt restriction) and/or sustained sodium loss induced by undeclared diuretics or cathartic drugs intake (anorexia nervosa). Regarding the latter, this can be induced by low serum oncosis due to significant hypoalbuminemia (serum albumin ≤ 2 mg/L) in malnourished patients or it could be secondary to advanced edematous states (heart failure, cirrhosis, etc.) which have already developed malnutrition [1, 19].
It has been documented that angiotensin II is a common mediator of muscle wasting and hyponatremia. Regarding the former, angiotensin II receptor type 1 is expressed in skeletal muscle and regulates its function, whereas elevated angiotensin II levels have been implicated in skeletal muscle atrophy. Regarding the latter, it has been described that elevated angiotensin II levels can be associated with polydipsia, and consequently, it can induce hyponatremia in some particular clinical settings (chronic kidney disease, etc.). Finally, inflammation-induced hyponatremia, mediated by inadequate vasopressin release, could also be a potential mechanism since angiotensin II is a proinflammatory factor [1].
Anorexia
Anorexia of any origin is one of the hyponatremia inducing mechanisms in malnourished patients. This mechanism mainly induces hyponatremia by altering body electrolyte composition, as explained above. In a particular sort of anorexia, the anorexia nervosa [14, 22], which is the most life-threatening of all psychiatric diseases, medical complications due to malnutrition and/or purging behaviors are the main cause of mortality in these patients. In this sense, they are more susceptible to sodium and water depletion due to diuretic and/or laxative abuse, and vomiting in a context of inadequate intake of fluids and sodium in defect of sodium (long-term sodium restriction). This nutritional behavior of not adding salt to food is usually used as a method to control body weight in this population. An inadequate vasopressin secretion can also contribute to induced hyponatremia in these patients [23].
Conclusion
Malnutrition can induce hyponatremia through hydro-electrolytic, hormonal, inflammatory, or nutritional behavior changes; while hyponatremia per se can induce malnutrition, then there is a pathophysiological feedback between both conditions.
References
Musso CG, Vilas M (2019) Water, electrolyte, and acid-base disorders in the elderly. In: Nephrogeriatrics Clinical (ed) Clinical Nephrogeriatrics. An Evidence-Based Guide. Springer, Cham, pp 43–62
Kovesdy CP, Kopple JD, Kalantar-Zadeh K (2013) Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr 97(6):1163–1177
Hanna RM, Ghobry L, Wassef O et al (2020) A practical approach to nutrition, protein-energy wasting, sarcopenia, and cachexia in patients with chronic kidney disease. Blood Purif 49(1–2):202–211
Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease. Kidney Int 73(4):391–398
Carrero JJ, Thomas F, Nagy K et al (2018) Global prevalence of protein-energy wasting in kidney disease: a meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr 28(6):380–392. https://doi.org/10.1053/j.jrn.2018.08.006. (PMID: 30348259)
Gracia-Iguacel C et al (2014) Defining protein-energy wasting syndrome in chronic kidney disease: prevalence and clinical implications. Nefrologia 34:507–519
Gómez-Hoyos E, Buigues AO, Ballesteros Pomar MD et al (2019) Development of hyponatremia in non-critical patients receiving total parenteral nutrition: a prospective, multicenter study. Clin Nutr 38(6):2639–2644. https://doi.org/10.1016/j.clnu.2018.11.014
Dekker MJE, Marcelli D, Canaud B et al (2019) Unraveling the relationship between mortality, hyponatremia, inflammation and malnutrition in hemodialysis patients: results from the international MONDO initiative. Eur J Clin Nutr 70(7):779–784. https://doi.org/10.1038/ejcn.2016.49
Rhee CM, Ayus JC, Kalantar-Zadeh K (2019) Hyponatremia in the dialysis population. Kidney Int 4(6):769–780
Bertini V, Nicoletti C, Beker BM, Musso CG (2019) Sarcopenia as a potential cause of chronic hyponatremia in the elderly Med Hypotheses 127:46–48. https://doi.org/10.1016/j.mehy.2019.03.029
Feder J, Gomez JM, Serra-Aguirre F, Musso CG (2019) Reset osmostat: facts and controversies. Indian J Nephrol 29(4):232–234
Musso CG, Jauregui JR (2016) Hyponatremia secondary to reset osmostat in a very old individual: a case report and pathophysiologic proposal. Electron J Biomed 3:49–51
Poulikakos D, Marks V, Lelos N, Banerjee D (2014) Low serum sodium is associated with protein energy wasting and increased interdialytic weight gain in haemodialysis patients. Clin Kidney J 7(2):156–160. https://doi.org/10.1093/ckj/sft170
Caksen H, Odabaş D, Sar S et al (2001) Hyponatremic dehydration: an analysis of 78 cases. Int Urol Nephrol 33(3):445–448. https://doi.org/10.1023/a:1019563222488
Barsony J, Manigrasso MB, Xu Q et al (2013) Chronic hyponatremia exacerbates multiple manifestations of senescence in male rats. Age (Dordr) 35(2):271–288. https://doi.org/10.1007/s11357-011-9347-9
Musso CG, Juarez R, Glassock RJ (2018) Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients. Int Urol Nephrol 50(1):81–89. https://doi.org/10.1007/s11255-017-1614-y
Musso CG, Belloso WH, Glassock RJ (2016) Water, electrolytes, and acid-base alterations in human immunodeficiency virus infected patients. World J Nephrol 5(1):33–42. https://doi.org/10.5527/wjn.v5.i1.33
Fujisawa C, Umegaki H, Sugimoto T et al (2021) Mild hyponatremia is associated with low skeletal muscle mass, physical function impairment, and depressive mood in the elderly. BMC Geriatr 21(1):15. https://doi.org/10.1186/s12877-020-01955-4
Zevallos G, Oreopoulos DG, Halperin ML (2001) Hyponatremia in patients undergoing CAPD: role of water gain and/or malnutrition. Perit Dial Int 21(1):72–6
De Arteaga J (2019) Hyponatremia in peritoneal dialysis: free water overload hyperosmolarity or malnutrition? Bull Dial Domic 2(4):201–206. https://doi.org/10.25796/bdd.v2i4.21303
Kashiji A, Tajiri M, Chikugo M et al (2021) Hyponatremia is a prognostic factor in patients receiving nutrition support. Am J Med Sci 361(6):744–50. https://doi.org/10.1016/j.amjms.2020.11.025
Dekker MJE, van der Sande FM, van den Berghe F et al (2018) Fluid overload and inflammation axis. Blood Purif 45(1–3):159–165. https://doi.org/10.1159/000485153
Caregaro L, Di Pascoli L, Favaro A et al (2005) Sodium depletion and hemoconcentration: overlooked complications in patients with anorexia nervosa? Nutrition 21(4):438–445. https://doi.org/10.1016/j.nut.2004.08.022
Funding
Open Access funding provided by Colombia Consortium.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Baez, G., Chirio, M., Pisula, P. et al. Hyponatremia and malnutrition: a comprehensive review. Ir J Med Sci 193, 1043–1046 (2024). https://doi.org/10.1007/s11845-023-03490-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-023-03490-8